research Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
This review details the skin and hematological toxicities of tyrosine kinase inhibitors like erlotinib, gefitinib, and imatinib, and highlights ongoing concerns about cardiac toxicity, reporting no new clinical findings.